CPT2 and hepatocellular carcinoma: Furthermore, the downregulation of carnitine palmatoyltransferase II (CPT2) in HCC has been shown to limit lipotoxicity from microenvironments characterized by excessive lipids and thus allow cancer cell growth [18].